Arnaud Scherpereel

6PUBLICATIONS
28CO-AUTHORS
Memory and attentionPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
Reply to: "Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743" and "Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743".

|Feb 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

Arnaud Scherpereel, Paul Baas, Anna K Nowak

|Feb 17, 2026
Optimising response to immunotherapies in pleural mesothelioma: clinical data and alternative models for the evaluation of new strategies.

Christophe Blanquart, Arnaud Scherpereel

|Jan 13, 2021
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133).

Stephen V Liu, Martin Reck, Aaron S Mansfield

|Jun 05, 2020
Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application.

Fabrice Denis, Simon Galmiche, Aurélien Dinh

|Feb 14, 2018
Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study.

Cecile Olivier, Jean-Marie Grosbois, Alexis B Cortot

Pageof 1

Frequent Collaborators

3 joint publications

Aaron S Mansfield

2 joint publications

Solange Peters

2 joint publications

Adam Lee

2 joint publications

Francesco Grossi